X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BIOCHEMICAL SOCIETY TRANSACTIONS

期刊標題檢索 BIOCHEM SOC T 最新評論: We still need to clearly explain the limitations of the research in th... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BIOCHEMICAL SOCIETY TRANSACTIONS]您好,您是該頁面的第 29363 位訪客。

期刊簡介
期刊名稱BIOCHEMICAL SOCIETY TRANSACTIONS BIOCHEMICAL SOCIETY TRANSACTIONS
LetPub Score
7.8
50 ratings
Rate

Reputation
8.8

Influence
6.5

Speed
9.7

期刊簡稱BIOCHEM SOC T
ISSN0300-5127
E-ISSN1470-8752
h-index131
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.801.6560.921
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Biochemistry
Q1105 / 438

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Biochemical Society Transactions is the reviews journal of the Biochemical Society. Publishing concise reviews written by experts in the field, providing a timely snapshot of the latest developments across all areas of the molecular and cellular biosciences.

Elevating our authors’ ideas and expertise, each review includes a perspectives section where authors offer comment on the latest advances, a glimpse of future challenges and highlighting the importance of associated research areas in far broader contexts.
官方網站http://www.biochemsoctrans.org/
在線稿件提交https://biochemsoctrans.msubmit.net/cgi-bin/main.plex
開放訪問No
出版商Portland Press Ltd.
主題領域生物
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年1973
每年文章數173每年文章數趨勢
黃金OA百分比54.36%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ2112/313
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0300-5127%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-6 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【BIOCHEMICAL SOCIETY TRANSACTIONS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1332297
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS575323
    JOURNAL OF BIOLOGICAL CHEMISTRY396194
    NUCLEIC ACIDS RESEARCH341773
    CELL298589
    FASEB JOURNAL270735
    International Journal of Biological Sciences241034
    PLANT SCIENCE228327
    Molecular Cancer228042
    ONCOGENE203903
  •  

    BIOCHEMICAL SOCIETY TRANSACTIONS BIOCHEMICAL SOCIETY TRANSACTIONS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [BIOCHEMICAL SOCIETY TRANSACTIONS] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:01:41 評論於
We still need to clearly explain the limitations of the research in the paper, and discuss how these limitations may impact the conclusions of the study. This will allow reviewers and other readers to understand that we have fully considered the limitations of the research. Addressing the limitations of the research in the discussion section often makes the paper more credible. Thinking about how to overcome these limitations in future research can have a positive effect
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:17:01 評論於
We recommend dividing the discussion of research limitations into three parts: (1) stating the research limitations; (2) explaining the research limitations in detail; and (3) proposing future research directions or improvement plans. Following this order to discuss research limitations can help you clearly point out the shortcomings of the research without compromising its quality and validity
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 17:11:37 評論於
How to address limitations in a discussion?
(0) 讚! | 北国博达

作者: 破戒阳平


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 11:56:55 評論於
Is it necessary to specify the limitations of the article in the discussion?
(0) 讚! | 破戒阳平

作者: 一只初翠呀


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-18 09:29:48 評論於
What does it mean to start counting this magazine days in folder from the beginning?
(0) 讚! | 一只初翠呀

作者: Piperacilin


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-06-02 01:37:58 評論於
It only accepts reviews. There is no submission link on the official website of the journal. You must write an application letter and specify the editor to confirm whether it meet the requirements of the inclusion of this journal. After the review is passed, the submission link will be sent to the author by email. The review speed after submission was fast, and minor revision was required in a month. Two weeks after the submission of revision, it was accepted. Mini review is preferred (3,000 to 4,000 words).

(0) 讚! | Piperacilin

作者: 黑山飞驰


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-01 08:25:37 評論於
Review Speed: 1.0 
Experience Sharing: Only accept review articles, there is no submission link on the journal's official website, you need to write a cover letter and specify the editor to review whether the submission meets the scope of the journal. After approval, the submission link will be sent to the author via email. The review process is very fast after submission, with minor revisions given within one month and acceptance within 2 weeks after revisions. The journal likes to receive mini reviews (3000-4000 words
(0) 讚! | 黑山飞驰

作者: Deirdre Alerander


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-27 17:36:56 評論於
This journal mainly includes review articles such as review, minireview, perspective, etc. The review process is quite fast, and I received feedback within three weeks. Overall, I feel it was smooth
(0) 讚! | Deirdre Alerander

作者: WTF


領域: 生物
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2019-05-27 10:32:25 評論於
This journal mainly accepts review articles (such as review, minireview, perspective, etc.). The review speed was very fast, and comments were received within three weeks. Overall, I feel it was pretty smooth.

(1) 讚! | WTF

作者: 凌霄高洁


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 15:28:58 評論於
It looks optimistic. If it rises a little more tomorrow, it may break through 3 points
(0) 讚! | 凌霄高洁

作者: 孤云子格


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-28 22:27:17 評論於
Research focus: Biochemistry
(0) 讚! | 孤云子格

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [BIOCHEMICAL SOCIETY TRANSACTIONS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*